Numerous classes of cancer therapies, including anthracyclines, fluoropyrimidines, VEGF inhibitors, TKIs targeting BCR-ABL, Bruton TKIs, proteasome inhibitors, ICI, alkylating agents, microtubule inhibitors, CART-cell therapy, and immunomodulatory drugs, can induce AF [9]. Here, VEGFA is linked to cancer.